{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/ALT/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T17:25:45.179Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":3462,"canonical_name":"Altimmune, Inc.","cik":"0001326190","uei":null,"lei":null,"duns":null,"ticker":"ALT"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":17,"clinical":1},"count":18,"timeline":[{"ts":"2026-10-05","kind":"sec.filing","form_type":"4","title":"4 — Altimmune, Inc. — 2026-10-05","url_slug":"/sec/cik-0001326190/4/0001802615-26-000002","accession_number":"0001802615-26-000002","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"3","title":"3 — Altimmune, Inc. — 2026-10-02","url_slug":"/sec/cik-0001326190/3/0002156820-26-000003","accession_number":"0002156820-26-000003","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — Altimmune, Inc. — 2026-10-02","url_slug":"/sec/cik-0001326190/4/0002156820-26-000004","accession_number":"0002156820-26-000004","importance":30},{"ts":"2026-09-29","kind":"sec.filing","form_type":"8-K","title":"8-K — Altimmune, Inc. — 2026-09-29","url_slug":"/sec/cik-0001326190/8-k/0001326190-26-000056","accession_number":"0001326190-26-000056","importance":35},{"ts":"2026-09-23","kind":"clinical.trial","reporter":"Altimmune, Inc.","title":"Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07795164","excerpt":"[\"Metabolic Dysfunction-Associated Steatohepatitis (MASH)\"]","importance":60},{"ts":"2026-09-17","kind":"sec.filing","form_type":"4","title":"4 — Altimmune, Inc. — 2026-09-17","url_slug":"/sec/cik-0001326190/4/0001595064-26-000002","accession_number":"0001595064-26-000002","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"4","title":"4 — Altimmune, Inc. — 2026-08-13","url_slug":"/sec/cik-0001326190/4/0001698665-26-000007","accession_number":"0001698665-26-000007","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Altimmune, Inc. — 2026-08-12","url_slug":"/sec/cik-0001326190/10-q/0001326190-26-000052","accession_number":"0001326190-26-000052","importance":45},{"ts":"2026-08-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Altimmune, Inc. — 2026-08-12","url_slug":"/sec/cik-0001326190/8-k/0001326190-26-000049","accession_number":"0001326190-26-000049","importance":35},{"ts":"2026-08-03","kind":"sec.filing","form_type":"4","title":"4 — Altimmune, Inc. — 2026-08-03","url_slug":"/sec/cik-0001326190/4/0001705905-26-000010","accession_number":"0001705905-26-000010","importance":30},{"ts":"2026-07-31","kind":"sec.insider.a","reporter":"WEAVER GREGORY L","title":"Chief Financial Officer","shares":1753,"price_per_share":2.414,"usd_value":4232,"security_title":"Common Stock, par value $0.0001","importance":15.004231742},{"ts":"2026-07-31","kind":"sec.insider.a","reporter":"Roberts M Scot","title":"Chief Scientific Officer","shares":875,"price_per_share":2.414,"usd_value":2112,"security_title":"Common Stock, par value $0.0001","importance":15.00211225},{"ts":"2026-07-28","kind":"sec.filing","form_type":"8-K","title":"8-K — Altimmune, Inc. — 2026-07-28","url_slug":"/sec/cik-0001326190/8-k/0001326190-26-000044","accession_number":"0001326190-26-000044","importance":35},{"ts":"2026-06-16","kind":"sec.filing","form_type":"8-K","title":"8-K — Altimmune, Inc. — 2026-06-16","url_slug":"/sec/cik-0001326190/8-k/0001104659-26-074575","accession_number":"0001104659-26-074575","importance":35},{"ts":"2026-05-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Altimmune, Inc. — 2026-05-13","url_slug":"/sec/cik-0001326190/10-q/0001326190-26-000040","accession_number":"0001326190-26-000040","importance":45},{"ts":"2026-05-13","kind":"sec.filing","form_type":"8-K","title":"8-K — Altimmune, Inc. — 2026-05-13","url_slug":"/sec/cik-0001326190/8-k/0001326190-26-000037","accession_number":"0001326190-26-000037","importance":35},{"ts":"2026-05-13","kind":"sec.filing","form_type":"S-8","title":"S-8 — Altimmune, Inc. — 2026-05-13","url_slug":"/sec/cik-0001326190/s-8/0001326190-26-000041","accession_number":"0001326190-26-000041","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Altimmune, Inc. — 2026-05-12","url_slug":"/sec/cik-0001326190/schedule-13g/0000093751-26-000201","accession_number":"0000093751-26-000201","importance":55}]}